	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	30/07/2018
	www.isa.gov.il			www.tase.co.il				Reference:	2018-02-071431	Time of broadcast: 13:51 13:47:09

Immediate Report

Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

Delay the publication of a report

_________

1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.

2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

BioLineRx Announces Expansion of Immuno-Oncology Collaboration in Pancreatic Cancer

6-K_BL-8040_300718_isa.pdf


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2018-02-005583


Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 01/07/2018
Address: HaMa'ayan 2 , Modi'in 7177871 , Israel Tel: 08-6429100 , Fax: 08-6429101
E-mail address: info@BioLineRx.com Company site: www.biolinerx.com

Previous names of reporting entity:

Name of the Signatory: Kotler Norman Harold Position of Signatory in the reporting corporation: General Counsel & Company Secretary Name of Employer Company:
Address: HaMa'ayan 2 , Modi'in 7177871 Telephone: 08-6429100 Facsimile: 08-6429101 E-mail: normank@biolinerx.com 1
Israel